SBIO

ALPS Medical Breakthroughs ETF SBIO

51.48 $ 0.51 %

Market capitalization

  • Market capitalization is the valuation at market price of all the outstanding shares of a stock company.

    • $ 128.696 M

    Ratio P/E

  • It allows you to evaluate the value of a security relative to the securities of companies in the same sector: in principle, a lower PER indicates a cheap stock, a higher PER an expensive stock compared to other companies.

    • 0.00

    Volume

  • Volume is the number of shares of a security traded during a given period of time.

    • 10.733 K

    Beta

  • The beta coefficient is the key coefficient of the financial asset pricing model (CAPM).

    • 1.35

    EPS

  • Earnings per share is the net profit of a company divided by the number of shares that make up its capital.

    • 0.00

    Dividend

  • A dividend is a payment from a company to its shareholders.

    • $ 1.174

    Price History

    Loading data...

    Inside ALPS Medical Breakthroughs ETF

    Symbol Name Share number Weight Value
    KYMR Kymera Therapeutics Inc. 64723 3.715 % 4.868 M $
    CELC Celcuity Inc. 37894 3.31 % 4.338 M $
    CRNX Crinetics Pharmaceuticals Inc. 77765 3.289 % 4.310 M $
    GPCR Structure Therapeutics Inc. 49726 3.2 % 4.193 M $
    ALKS Alkermes PLC 135379 3.163 % 4.145 M $
    MIRM Mirum Pharmaceuticals Inc. 42097 2.912 % 3.816 M $
    ACAD ACADIA Pharmaceuticals Inc. 138719 2.843 % 3.726 M $
    APGE Apogee Therapeutics Inc. 44922 2.826 % 3.703 M $
    CGON CG oncology Inc. 66037 2.797 % 3.666 M $
    FOLD Amicus Therapeutics Inc. 252834 2.774 % 3.636 M $
    VKTX Viking Therapeutics Inc. 92616 2.427 % 3.180 M $
    NAMS Newamsterdam Pharma Co. NV 92902 2.263 % 2.965 M $
    IDYA Ideaya Biosciences Inc. 71789 2.029 % 2.658 M $
    XENE Xenon Pharmaceuticals Inc. 63302 2.009 % 2.632 M $
    TARS Tarsus Pharmaceuticals Inc. 34755 1.995 % 2.615 M $
    VERA Vera Therapeutics Inc. 52392 1.935 % 2.536 M $
    EWTX Edgewise Therapeutics Inc. 86829 1.867 % 2.446 M $
    IRON Disc Medicine Inc. 30902 1.818 % 2.382 M $
    DNLI Denali Therapeutics Inc. 120518 1.68 % 2.202 M $
    MLYS Mineralys Therapeutics Inc. 64887 1.655 % 2.168 M $
    TVTX Travere Therapeutics Inc. 73263 1.617 % 2.119 M $
    SYRE Spyre Therapeutics Inc. 63608 1.61 % 2.109 M $
    APLS Apellis Pharmaceuticals Inc. 103696 1.609 % 2.108 M $
    SRPT Sarepta Therapeutics Inc. 85937 1.495 % 1.959 M $
    OLMA Olema Pharmaceuticals Inc. 64492 1.416 % 1.855 M $
    GLPG Galapagos NV 53691 1.398 % 1.832 M $
    ZLAB Zai Lab Ltd. 92107 1.378 % 1.806 M $
    NUVB Nuvation Bio Inc. 280899 1.353 % 1.772 M $
    DNTH Dianthus Therapeutics Inc. 35206 1.244 % 1.630 M $
    MAZE Maze Therapeutics Inc. 39414 1.236 % 1.620 M $
    MBX MBX Biosciences Inc. 36872 1.21 % 1.585 M $
    VCEL Vericel Corp. 41526 1.183 % 1.550 M $
    SION Sionna Therapeutics Inc. 36548 1.148 % 1.505 M $
    DVAX Dynavax Technologies Corp. 96419 1.148 % 1.504 M $
    STOK Stoke Therapeutics Inc. 46896 1.108 % 1.452 M $
    CLDX Celldex Therapeutics Inc. 54559 1.097 % 1.437 M $
    UPB Upstream Bio Inc. 44376 1.094 % 1.433 M $
    MNKD MannKind Corp. 252142 1.079 % 1.415 M $
    AGIO Agios Pharmaceuticals Inc. 47881 1.05 % 1.376 M $
    IMCR Immunocore Holdings PLC 41487 1.049 % 1.374 M $
    PHVS Pharvaris NV 52592 1.029 % 1.348 M $
    TYRA Tyra Biosciences Inc. 43827 0.977 % 1.280 M $
    ORKA Oruka Therapeutics Inc. 39751 0.971 % 1.272 M $
    AMLX Amylyx Pharmaceuticals Inc. 90172 0.968 % 1.269 M $
    RLAY Relay Therapeutics Inc. 142321 0.876 % 1.149 M $
    TSHA Taysha Gene Therapies Inc. 224920 0.865 % 1.134 M $
    OCS Oculis Holding AG 46947 0.848 % 1.111 M $
    NVAX Novavax Inc. 133432 0.834 % 1.093 M $
    IMTX Immatics NV 110082 0.826 % 1.082 M $
    RAPP Rapport Therapeutics Inc. 39139 0.819 % 1.073 M $
    PVLA Palvella Therapeutics Inc. 9716 0.781 % 1.023 M $
    MLTX MoonLake Immunotherapeutics 58169 0.773 % 1.013 M $
    ZBIO Zenas Biopharma Inc. 43977 0.757 % 992.121 K $
    SPRY ARS Pharmaceuticals Inc. 81168 0.73 % 956.971 K $
    DAWN Day One Biopharmaceuticals Inc. 84304 0.69 % 904.582 K $
    CMPX Compass Therapeutics Inc. 146040 0.673 % 882.082 K $
    TBPH Theravance Biopharma Inc. 41608 0.654 % 857.541 K $
    XNCR Xencor Inc. 58639 0.647 % 847.334 K $
    BCAX Bicara Therapeutics Inc. 44978 0.618 % 810.504 K $
    AVBP ArriVent Biopharma Inc. 33896 0.581 % 761.643 K $
    FLGT Fulgent Genetics Inc. 25385 0.542 % 710.018 K $
    GERN Geron Corp. 524159 0.54 % 707.615 K $
    KURA Kura Oncology Inc. 71447 0.51 % 668.744 K $
    KALV KalVista Pharmaceuticals Inc. 41503 0.483 % 632.506 K $
    RGNX REGENXBIO Inc. 41568 0.474 % 621.442 K $
    ATXS Astria Therapeutics Inc. 46874 0.449 % 587.800 K $
    RIGL Rigel Pharmaceuticals Inc. 14900 0.445 % 582.888 K $
    DSGN Design Therapeutics Inc. 46771 0.35 % 458.356 K $
    ANRO Alto Neuroscience Inc. 25505 0.334 % 437.666 K $
    CRVS Corvus Pharmaceuticals Inc. 61318 0.319 % 418.189 K $
    VNDA Vanda Pharmaceuticals Inc. 48522 0.285 % 373.619 K $
    ALT Altimmune Inc. 85677 0.273 % 358.130 K $
    AVXL Anavex Life Sciences Corp. 73361 0.27 % 353.600 K $
    FBRX Forte Biosciences Inc. 10289 0.252 % 330.174 K $
    TECX Tectonic Therapeutic Inc. 15369 0.231 % 302.308 K $
    DCTH Delcath Systems Inc. 28999 0.23 % 301.010 K $
    AKBA Akebia Therapeutics Inc. 217891 0.229 % 300.690 K $
    ZURA Zura Bio Ltd. 53389 0.219 % 286.699 K $
    CADL Candel Therapeutics Inc. 45079 0.214 % 279.941 K $
    BCYC Bicycle Therapeutics PLC 40995 0.207 % 271.387 K $
    AARD Aardvark Therapeutics Inc. 17877 0.204 % 267.797 K $
    ACRS Aclaris Therapeutics Inc. 88965 0.186 % 243.764 K $
    NGNE Neurogene Inc. 12721 0.182 % 239.155 K $
    AVIR Atea Pharmaceuticals Inc. 64154 0.173 % 227.105 K $
    TARA Protara Therapeutics Inc. 42389 0.16 % 209.402 K $
    RZLT Rezolute Inc. 76143 0.158 % 207.109 K $
    ARCT Arcturus Therapeutics Holdings Inc. 23325 0.138 % 180.302 K $
    2600057D Novo Nordisk A/S 1233 0 % 0.120 $
    1835589D Chinook Therapeutics Inc. 20700 0 % 0.020 $
    2334482D AstraZeneca PLC 36586 0 % 0.040 $
    Cash and Equivalents -172.74 0 % -172.740 $